| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.46 | 0.02 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | 0.44 | 0.02 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |